Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNOT7 | Q9UIV1 | 7/20 | 0.50 |
| ▸ | PARN | O95453 | 1/20 | 0.50 |
| ▸ | P2RX3 | P56373 | 8/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22105580 | 0.82 | LMNA (0.49) | CNOT7P2RX3MEN1KMT2ALMNA | |
| SCHEMBL20652797 | 0.80 | HIF1A (0.46) | P2RX3MEN1KMT2ALMNATHRB | |
| SCHEMBL20656191 | 0.79 | CNOT7 (0.38) | CNOT7P2RX3MEN1KMT2A | |
| SCHEMBL20656028 | 0.77 | CNOT7 (0.36) | CNOT7P2RX3MEN1KMT2A | |
| SCHEMBL16058231 | 0.75 | ADORA2B (0.55) | P2RX3MEN1KMT2A | |
| SCHEMBL20655999 | 0.74 | P2RX3 (0.45) | P2RX3 | |
| SCHEMBL22105587 | 0.74 | P2RX3 (0.47) | P2RX3MEN1KMT2ALMNATHRB | |
| SCHEMBL20656007 | 0.73 | P2RX3 (0.44) | P2RX3LMNATHRBNPSR1L3MBTL1 | |
| SCHEMBL20652795 | 0.72 | P2RX3 (0.47) | P2RX3KMT2ANPSR1L3MBTL1 | |
| SCHEMBL17538686 | 0.72 | KDM4C (0.39) | P2RX3MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019011802-A1 | NOVEL SUBSTITUTED XANTHINE DERIVATIVES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2019-01-17 | — | — | WO | disclosed |